Compositions and methods for combination antiviral therapy

Details for Australian Patent Application No. 2009200414 (hide)

Owner Gilead Sciences, Inc.

Inventors Menning, Mark M.; Oliyai, Reza; Dahl, Terrence C.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009200414

Parent 2004206821

Filing date 4 February 2009

Wipo publication date 26 February 2009

Acceptance publication date 8 December 2011

International Classifications

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/7076 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

19 February 2009 Complete Application Filed

26 February 2009 Application Open to Public Inspection

  Published as AU-B-2009200414

8 December 2011 Application Accepted

  Published as AU-B-2009200414

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009200415-Processing of alpha-beta titanium alloy workpieces for good ultrasonic inspectability

2009200413-Human Mobility Assistant